Documents — Subject Listing
Breast Implants
Direct-to-Consumer Advertising (DTCA)
- The DTCA CanWest Charter Challenge , June 15, 2009.
- Complaint Letter to Minister Tony Clement Regarding DTCA of Celebrex, March 14, 2006.
- Complaint letter to Health Canada: Pfizer "toe-tag" ad, 2004.
- Direct-to-Consumer Prescription Drug Advertising: When Public Health is No Longer a Priority, pdf version, by Barbara Mintzes and Rosanna Baraldi, 2001.
- Direct-to-Consumer Advertising of prescription drugs, by Barbara Mintzes, 2000.
- "WHP opposes direct-to-consumer-advertising of prescription drugs!" Posters
DTCA Articles - From Other Sources
- Influence of Direct to Consumer Pharmaceutical Advertising and Patients' Requests on Prescribing Decisions: Two Site Cross Sectional Survey, pdf version, British Medical Journal, by Barbara Mintzes,M.L. Barer, R.L. Kravitz, A. Kazanjian, K. Bassett, J. Lexchin, R.g. Evans, R. Pan, S. Marion, February 2002.
- The Marketing of Fear, Australian Financial Review, by Ray Moynihan, June 2000.
DTCA: CanWest Charter Challenge
Emergency Contraception
- Improving Access to Emergency Contraception (327KB pdf), May 2005.
Funding and other Policy Issues
- Marching to Different Drummers: Health Advocacy Groups in Canada and Funding from the Pharmaceutical Industry (231KB pdf), by Sharon Batt for Women and Health Protection, January 2005.
- A Different Prescription:Considerations for Women's Health Groups Contemplating Funding from the Pharmaceutical Industry, by Anne Rochon Ford, 1999.
Health Protection Legislation
- Submission from WHP to Health Canada in response to Blueprint for Renewal: Transforming Canada 's Approach to Regulating Health Products and Food, November 2006.
- Brief to the Office of Legislative Renewal from Women and Health Protection (84KB pdf), 2004.
- Report of the Royal Commission on the Future of Health Care in Canada: Response from the Women and Health Protection (WHP) Working Group, January 2003.
- An Open Letter to WTO members, December 2002.
- What should public consultation look like?, by Barbara Mains, July 2000.
- To Do No Harm: Why women are concerned about the dismantling of health protection legislation in Canada, by The Working Group on Women and Health Protection, 1998.
Pharmaceuticals/Prescription Drugs
- Mental Health and Pregnancy: An Exploration of Issues Regarding the Use of Prescription Medications , (526KB), December 2010
- Pharmaceuticals Manufacturing: What do We Know about the Occupational Health and Safety Hazards for Women Working in the Industry? (430KB), March 2009
- Evidence for Caution: What Women Need to Know about Statins (Facts to Act on Series) (342KB), March 2009
- Ten Good Reasons to Be Concerned about the Human Papillomavirus (HPV) Vaccination Campaign (118KB), February 2009
- The HPV Vaccine: Information for Parents(and Others Considering It) (658KB), January 2009
- Reflections on Depo Provera: Contributions to Improving Drug Regulation in Canada (166KB), July 2008
- Evidence for Caution: Women and statin use (347KB pdf), June 2007.
- Remembering Ruth Cooperstock: Women and pharmaceuticals 20 years later (470KB pdf). Symposium proceedings, April 2006.
- The Inclusion of Women in Clinical Trials: Are We Asking the Right Questions? (386KB pdf), by Abby Lippman for Women and Health Protection, March 2006.
- Transparency and the Drug Approval Process at Health Canada, A Policy Brief, pdf version, March 2006.
- Transparency and the Drug Approval Process at Health Canada (252KB pdf), by Ann Silversides for Women and Health Protection, December 2005. (Abstract in HTML format.)
- SSRI antidepressants: their place in women’s lives, October 2005.
- Improving Access to Emergency Contraception (327KB pdf), May 2005.
- The Marketization of Depression: The Prescribing of SSRI Antidepressants to Women (261KB pdf), by Janet Currie for Women and Health Protection, May 2005.
- Drug regulatory failure in Canada: The case of Diane-35, pdf version, by Barbara Mintzes for Women and Health Protection, 2004.
- Evra and the Environment, by Suzanne Elston for Women and Health Protection, 2004.
- Pharmaceuticals in Our Water: A New Threat to Public Health?, pdf version, by Sharon Batt for Women and Health Protection, 2004.
- Full Circle: Drugs, the Environment and Our Health, pdf version, by Sharon Batt for Women and Health Protection, July 2003.
- How Safe Are Our Medicines? "Monitoring the risks of drugs after they are approved for marketing", pdf version, by Barbara Mintzes for Women and Health Protection, second edition, 2003.
- Preventing Disease: Are Pills the Answer?, pdf version, by Sharon Batt, 2002.
- Who Benefits? International Harmonisation of the Regulation of New Pharmaceutical Drugs, pdf version, 2002. Based on a paper by John Abraham
- International Harmonisation of Pharmaceuticals: Key Issues of Concern for Public Health, by John Abraham, 2001.
Post-Market Surveillance and ADR Reporting
- Post-Market Surveillance of Therapeutic Drugs in Canada, by Colleen Fuller and Diane Saibil for Women and Health Protection, May 2005.
- Reporting Harm Caused by Medicines, by Colleen Fuller and Diane Saibil for Women and Health Protection, 2005.
- Women and Adverse Drug Reactions, Reporting in the Canadian Context (113KB pdf), by Colleen Fuller for Women and Health Protection, 2002. Revised August 2003.
Copyright ©2006-2010 Women and Health Protection